We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Investigator and Institution Sample Clauses

Investigator and Institution acknowledge that CRO is the recipient of Services described in this Agreement and, for the avoidance of any doubt, that SPONSOR is not the recipient of Services described in this Agreement.
Sample 1Sample 2Sample 3See All (6)
Investigator and Institution shall ensure the prompt, complete, and accurate collection, recording and classification of the Medical Records, Study Results and of all clinical supplies, equipment and Study Drug provided by SPONSOR or CRO or its Affiliates and shall store such materials according to the Protocol or Study Instructions. Institution and Investigator shall : (i) maintain and store Medical Records and Study Results in a secure manner with physical and electronic access restrictions, as applicable and environmental controls appropriate to the applicable data type and in accordance with Applicable Laws, regulations and industry standards; and (ii) protect the Medical Records and Study Results from unauthorized use, access, duplication, and disclosure. If directed by Sponsor or CRO, Institution and Investigator will submit Study Results using the electronic system provided by Sponsor or CRO or their designated representative and in accordance with Sponsor’s instructions for electronic data entry. Institution and Investigator shall prevent unauthorized access to the Study Results by maintaining physical security of the electronic system and ensuring that Study Personnel maintain the confidentiality of their passwords. Investigator agrees to collect all Study Results in Medical Records prior to entering it into the eCRF/CRF. Institution and Investigator shall ensure the prompt submission of eCRFs/CRFs; and (iii) take measures to prevent accidental or premature destruction or damage of these documents, for as long as agreed herewith. 2.10 a) The Medical Records and Study Data shall be retained for a minimum of twenty five (25) years from the Institution´s close out visit or for the duration required by Applicable Law, whichever is longer. In compliance with Sponsor’s obligations under ICH GCP, Sponsor shall notify the Institution in writing if the Medical Records and Study Data are no longer needed before the completion of the minimum retention period agreed herewith. In case Institution will be closed or no longer available for record retention for any reason, Institution must notify Sponsor in writing at least sixty (60) days in advance and perform any instruction to transfer the Medical Records and Study Data as provided by Sponsor. Any inquiries or requests regarding record retention can be sent at any time during the retention period to the email address , but in no circumstance shall Institution be allowed to destroy or permit the destruction of the Medical Records and Stud...
Sample 1See All (5)
Investigator and Institution. 2.1 Investigator represents and warrants that Investigator holds the necessary qualifications and has the necessary expertise, time and resources to conduct the Clinical Trial, and that the terms of this Agreement are not inconsistent with any other contractual or legal obligations that Investigator may have, or with Institution’s policies or procedures, or the policies and procedures of any institution or company with which Investigator is associated. Investigator shall during the Term: (i) remain a member in good standing of the applicable College of Physicians and Surgeons (without any terms, limitations or conditions);
Sample 1Sample 2Sample 3
Investigator and Institution. 2.1 Investigator represents and warrants that Investigator holds the necessary qualifications and has the necessary expertise, time and resources to conduct the Clinical Trial, and that the terms of this Agreement are not inconsistent with any other contractual or legal obligations that Investigator may have, or with Institution’s policies or procedures, or the policies and procedures of any institution or company with which Investigator is associated. Investigator shall during the Term: (i) remain a member in good standing of the applicable College of Physicians and Surgeons (without any terms, limitations or conditions); (ii) remain a member of the Canadian Medical Protective Association, or have equivalent professional liability insurance coverage; and
Sample 1
Investigator and Institution acknowledge that SPONSOR is the sponsor of the Study, and as such is an intended third-party beneficiary of this Agreement, whereas SPONSOR transfers any or all of the SPONSOR's Study- related functions to CRO in compliance with ICH-GCP, sec. 5. 2.1. In addition to the foregoing, Investigator and Institution agree that CRO may disclose any and all Information and/or documents relating to this Agreement, and/or relating to Investigator’s and Institution’s participation in the Study (including without limitation any Reports or other documents or materials provided by Investigator or Institution to CRO hereunder), to SPONSOR. All references to SPONSOR herein (whether in the context of delivery of Information, submission of applications, financial terms, or anything else) derive from SPONSOR’s status as such, as set out by Applicable Law and GCP regulations, and Investigator and Institution agree to all such instances. Investigator and Institution will Fully Cooperate with CRO’s requests relating to SPONSOR.
Sample 1
Investigator and Institution shall ensure the prompt, complete, and accurate collection, recording and classification of the Medical Records, Study Results and of all clinical supplies, equipment and Study Drug provided by SPONSOR or CRO or its Affiliates and shall store such materials according to the Protocol or Study Instructions. Institution and Investigator shall : (i) maintain and store Medical Records and Study Results in a secure manner with physical and electronic access restrictions, as applicable and environmental controls appropriate to the applicable data type and in accordance with Applicable Laws, regulations and industry standards; and (ii) protect the Medical Records and Study Results from unauthorized use, access, duplication, and disclosure. If directed by Sponsor or CRO, Institution and Investigator will submit Study Results using the electronic system provided by Sponsor or CRO or their designated representative and in accordance with Sponsor’s instructions for electronic data entry. Institution and Investigator shall prevent unauthorized access to the Study Results by maintaining physical security of the electronic system and ensuring that Study Personnel maintain the confidentiality of their passwords. Investigator agrees to collect all Study Results in Medical Records prior to entering it into the eCRF/CRF. Institution and Investigator shall ensure the prompt submission of eCRFs/CRFs; and (iii) take measures to prevent accidental or premature destruction or damage of these documents, for as long as agreed herewith.
Sample 1
Investigator and Institution. 3.1 The Investigator represents and warrants that he holds the necessary qualifications and has the necessary expertise, time, and resources to perform the Clinical Study and that the terms of this Agreement are not inconsistent with any other contractual or legal obligations that the Investigator may have, or with the Institution’s policies or procedures or the policies and procedures of any institution or company with which the Investigator is associated. The Investigator shall through the duration of the Clinical Study: (i) remain a member in good standing of the applicable College of Physicians and Surgeons or such other health profession regulatory body with which the Investigator is registered or of which the Investigator is a member; (ii) have a professional liability insurance coverage; and (iii) immediately notify the other Parties in writing if such status changes during the term of this Agreement. 3.2 The Institution and the Investigator shall recruit and ensure the performance of the obligations of the Study Staff as set out in this Agreement. 3.3 The Institution and the Investigator shall be responsible and liable for the acts and omissions of their own employees and Agents in connection with the Clinical Study, as if such acts and omissions were those of the Institution or the Investigator. 3.4 The Institution and the Investigator represent and warrant that they are not currently using, and shall not knowingly use the services of any person, including the Investigator, who is debarred, proposed for debarment or otherwise disqualified or suspended from performing a clinical study or otherwise subject to any restrictions or sanctions by any Regulatory Authority or EC with respect to the performance of scientific or clinical investigations. The Institution and the Investigator will immediately notify Sponsor if either of them becomes aware of any such debarment, proposal for such debarment, disqualification or suspension.
Sample 1
Investigator and Institution. 2.1 The Investigator represents and warrants that he or she holds the necessary qualifications and has the necessary expertise, time and resources to perform the Clinical Trial and that the terms of this Agreement are not inconsistent with any other contractual or legal obligations that the Investigator may have, or with the Institution’s policies or procedures or the policies and procedures of any institution or company with which the Investigator is associated. The Investigator shall through the duration of the Clinical Trial: (i) remain a member in good standing of the applicable College of Physicians and Surgeons or such other health profession regulatory body with which the Investigator is registered or of which the Investigator is a member; (ii) remain a member of the Canadian Medical Protective Association, or have equivalent professional liability insurance coverage; and (iii) immediately notify the other Parties in writing if such status changes during the term of this Agreement. 2.2 The Institution and the Investigator shall recruit and ensure the performance of the obligations of the Trial Site Team Members as set out in this Agreement. 2.3 The Institution and the Investigator shall be responsible and liable for the acts and omissions of their own employees and Agents in connection with the Clinical Trial, as if such acts and omissions were those of the Institution or the Investigator. 2.4 The Institution and the Investigator represent and warrant that they are not currently using, and shall not knowingly use the services of any person, including the Investigator, who is debarred, proposed for debarment or otherwise disqualified or suspended from performing a clinical study or otherwise subject to any restrictions or sanctions by any Regulatory Authority or REB with respect to the performance of scientific or clinical investigations. The Institution and the Investigator will immediately notify Sponsor if either of them becomes aware of any such debarment, proposal for such debarment, disqualification or suspension.
Sample 1

Related to Investigator and Institution

  • Institution and Investigator acknowledge and agree that its, his or her judgment with respect to its, his or her advice to and care of each Subject is not and shall not be affected by the compensation Institution and/or Investigator receive in accordance with the Study.

  • Investigator Where a difference arises between the parties relating to the dismissal, discipline or suspension of an employee, or to the interpretation, application, operation or alleged violation of this agreement, including any questions as to whether a matter is arbitrable, during the term of the collective agreement, an arbitrator agreed to by the parties shall, at the request of either party: (a) investigate the difference; (b) define the issue in the difference; and (c) make written recommendations to resolve the difference within five days of the date of receipt of the request and for those five days from that date time does not run in respect of the grievance procedure. The parties agree that this procedure will not be invoked until the grievance procedure has been completed.

  • Institution For the purposes of these Terms and Conditions, the “Institution” means the institution purchasing goods and services for which a Purchase Order has been lawfully issued to the Vendor.

  • SENDING INSTITUTION Country: ............................................................

  • COMPLAINTS AND INVESTIGATIONS 1. This article applies to complaints or allegations made externally and not from normal supervisory activities. 2. A department head shall be responsible for ensuring that all allegations of misconduct or other complaints against an employee on which any action is to be taken or a record is to be made shall be investigated. The investigator shall be allowed to interview the complainant prior to notifying the employee.

  • AUDITS AND INVESTIGATIONS 27.1 Each invoice paid by UNDP shall be subject to a post-payment audit by auditors, whether internal or external, of UNDP or by other authorized and qualified agents of UNDP at any time during the term of the Contract and for a period of three (3) years following the expiration or prior termination of the Contract. 27.2 UNDP may conduct investigations relating to any aspect of the Contract or the award thereof, the obligations performed under the Contract, and the operations of the Contractor generally relating to performance of the Contract at any time during the term of the Contract and for a period of three 27.3 The Contractor shall provide its full and timely cooperation with any such inspections, post- payment audits or investigations. Such cooperation shall include, but shall not be limited to, the Contractor’s obligation to make available its personnel and any relevant documentation for such purposes at reasonable times and on reasonable conditions and to grant to UNDP access to the Contractor’s premises at reasonable times and on reasonable conditions in connection with such access to the Contractor’s personnel and relevant documentation. The Contractor shall require its agents, including, but not limited to, the Contractor’s attorneys, accountants or other advisers, to reasonably cooperate with any inspections, post-payment audits or investigations carried out by UNDP hereunder. 27.4 UNDP shall be entitled to a refund from the Contractor for any amounts shown by such audits or investigations to have been paid by UNDP other than in accordance with the terms and conditions of the Contract. The Contractor also agrees that, where applicable, donors to UNDP whose funding is the source of, in whole or in part, the funding for the procurement of Goods and/or Services which are the subject of this Contract, shall have direct recourse to the Contractor for the recovery of any funds determined by UNDP to have been used in violation of or inconsistent with this Contract.

  • Credit to Other Postsecondary Institutions Complete Articulation Agreement-Student will have to take at least one course at SSC to transfer articulated credit. (College Credit Plus courses apply) For questions, please feel free to contact, Xxxxxx XxXxxxx at 000-000-0000 X0000 or email – Xxxxxxxx@xxxxxxxxxx.xxx • Xxxxxxxxx High School – Web Programming & Design Student: Please complete the upper portion of this application and forward it to your high school program teacher to complete the lower portion. Credit for advanced standing courses will be given at the end of the college semester. Please be sure Xxxxx State College (SSC) has a copy of your final High School Transcript. The student must enroll in at least one course at SSC within one year of high school graduation to be eligible to receive articulated credit(s). The student must successfully complete the SSC course to receive articulated credit(s).

  • Investigatory Interview When the employee under investigation is to be interviewed concerning the alleged conduct which could result in discharge or other discipline, the employee and his or her representative shall be notified in writing, at least forty-eight (48) hours prior to the interview. In the event of an emergency, such reasonable notice as the circumstances permit shall be given. The notice shall state that an official investigation is being conducted and shall state the subject matter of the investigatory interview. a. Prior to being interviewed pursuant to this section, the employee shall be afforded a reasonable opportunity and facilities to contact and consult privately with his or her union representative or union attorney. b. Any interview of an employee under this section shall be conducted at a reasonable time, at a suitable location and, when practicable, on the department’s premises when the employee is on duty. The union representative or union attorney may participate in the interview. c. The interview shall be limited to questions that are directly, narrowly, and specifically related to the employee’s job performance as it relates to the allegation(s) or complaints. The employee shall not be subjected to any offensive language nor be threatened with transfer, dismissal or other disciplinary action. Confidentiality of the interview shall be maintained.

  • Agreements with Foreign Banking Institutions Each agreement with a foreign banking institution shall provide that: (a) the assets of each Portfolio will not be subject to any right, charge, security interest, lien or claim of any kind in favor of the foreign banking institution or its creditors or agent, except a claim of payment for their safe custody or administration; (b) beneficial ownership for the assets of each Portfolio will be freely transferable without the payment of money or value other than for custody or administration; (c) adequate records will be maintained identifying the assets as belonging to each applicable Portfolio; (d) officers of or auditors employed by, or other representatives of the Custodian, including to the extent permitted under applicable law the independent public accountants for the Fund, will be given access to the books and records of the foreign banking institution relating to its actions under its agreement with the Custodian; and (e) assets of the Portfolios held by the foreign sub-custodian will be subject only to the instructions of the Custodian or its agents.

  • Disqualified Institutions (i) Notwithstanding anything to the contrary set forth herein, no assignment or participation shall be made to any Person that was a Disqualified Institution as of the date (the “Trade Date”) on which the assigning Lender entered into a binding agreement to sell and assign all or a portion of its rights and obligations under this Agreement to such Person (unless the Company has consented to such assignment in writing in its sole and absolute discretion, in which case such Person will not be considered a Disqualified Institution for the purpose of such assignment or participation). For the avoidance of doubt, with respect to any assignee that becomes a Disqualified Institution after the applicable Trade Date (including as a result of the delivery of a notice pursuant to, and/or the expiration of the notice period referred to in, the definition of “Disqualified Institution”), (x) such assignee shall not retroactively be disqualified from becoming a Lender and (y) the execution by the Company of an Assignment and Assumption with respect to such assignee will not by itself result in such assignee no longer being considered a Disqualified Institution. Any assignment in violation of this subsection (f)(i) shall not be void, but the other provisions of this subsection (f) shall apply. (ii) If any assignment or participation is made to any Disqualified Institution without the Company’s prior written consent in violation of subsection (f)(i) above, or if any Person becomes a Disqualified Institution after the applicable Trade Date, the Company may, at its sole expense and effort, upon notice to the applicable Disqualified Institution and the Administrative Agent, (A) terminate the Commitment of such Disqualified Institution and repay all obligations of the Borrowers owing to such Disqualified Institution in connection with such Commitment, (B) in the case of outstanding Loans held by Disqualified Institutions, purchase or prepay such Loans by paying the lesser of (x) the principal amount thereof and (y) the amount that such Disqualified Institution paid to acquire such Loans, in each case plus accrued interest, accrued fees and all other amounts (other than principal amounts) payable to it hereunder and/or (C) require such Disqualified Institution to assign, without recourse (in accordance with and subject to the restrictions contained in this Section 10.06), all of its interest, rights and obligations under this Agreement to one or more Eligible Assignees at the lesser of (x) the principal amount thereof and (y) the amount that such Disqualified Institution paid to acquire such interests, rights and obligations, in each case plus accrued interest, accrued fees and all other amounts (other than principal amounts) payable to it hereunder. (iii) Notwithstanding anything to the contrary contained in this Agreement, Disqualified Institutions (A) will not (x) have the right to receive information, reports or other materials provided to Lenders by the Borrowers, the Administrative Agent or any other Lender, (y) attend or participate in meetings attended by the Lenders and the Administrative Agent, or (z) access any electronic site established for the Lenders or confidential communications from counsel to or financial advisors of the Administrative Agent or the Lenders and (B) (x) for purposes of any consent to any amendment, waiver or modification of, or any action under, and for the purpose of any direction to the Administrative Agent or any Lender to undertake any action (or refrain from taking any action) under this Agreement or any other Loan Document, each Disqualified Institution will be deemed to have consented in the same proportion as the Lenders that are not Disqualified Institutions consented to such matter, and (y) for purposes of voting on any plan of reorganization or plan of liquidation pursuant to any Debtor Relief Laws (a “Bankruptcy Plan”), each Disqualified Institution party hereto hereby agrees (1) not to vote on such Bankruptcy Plan, (2) if such Disqualified Institution does vote on such Bankruptcy Plan notwithstanding the restriction in the foregoing clause (1), such vote will be deemed not to be in good faith and shall be “designated” pursuant to Section 1126(e) of the Bankruptcy Code of the United States (or any similar provision in any other Debtor Relief Laws), and such vote shall not be counted in determining whether the applicable class has accepted or rejected such Bankruptcy Plan in accordance with Section 1126(c) of the Bankruptcy Code of the United States (or any similar provision in any other Debtor Relief Laws) and (3) not to contest any request by any party for a determination by the Bankruptcy Court (or other applicable court of competent jurisdiction) effectuating the foregoing clause (2). (iv) The Administrative Agent shall have the right, and the Borrowers hereby expressly authorizes the Administrative Agent, to (A) post the list of Disqualified Institutions provided by the Company and any updates thereto from time to time (collectively, the “DQ List”) on the Platform, including that portion of the Platform that is designated for “public side” Lenders and/or (B) provide the DQ List to each Lender requesting the same (it being understood that the Administrative Agent will provide the DQ List to any Lender following its request).

Most Referenced Clauses

Most Referenced Definitions